Hérvè Chambost

Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

Hideyuki Ikeda, Bernard Lethé, Frédéric Lehmann et al. · Immunity · 1997 · 765 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Nk Inhibitory Receptor +8

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

Samantha C. Gouw, H. Marijke van den Berg, Kathelijn Fischer et al. · Blood · 2013 · 319 citations

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A

Jenny Goudemand, Chantal Rothschild, Virginie Demiguel et al. · Blood · 2005 · 293 citations · Full text

<i>PRAME</i>, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells

Van Baren, Hérvè Chambost, Ferrant et al. · British Journal of Haematology · 1998 · 184 citations · Full text

Mixed-phenotype Acute Leukemia, Immune Regulation, Immunology +22

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

Johnny Mahlangu, Radosław Kaczmarek, Annette von Drygalski et al. · New England Journal of Medicine · 2023 · 176 citations · Full text